4//SEC Filing
Barth Jay 4
Accession 0001209191-20-049131
CIK 0001178879other
Filed
Sep 1, 8:00 PM ET
Accepted
Sep 2, 4:27 PM ET
Size
9.9 KB
Accession
0001209191-20-049131
Insider Transaction Report
Form 4
Barth Jay
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2020-08-31$6.10/sh+28,750$175,375→ 191,954 total - Exercise/Conversion
Stock Options (right to buy)
2020-08-31−28,750→ 1,250 totalExercise: $6.10Exp: 2026-06-15→ Common Stock (28,750 underlying) - Sale
Common Stock
2020-08-31$14.74/sh−28,750$423,746→ 163,204 total
Holdings
- 20(indirect: By Daughter)
Common Stock
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $14.58 to $14.88 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]All of the options were fully vested and exercisable as of the transaction date.
Documents
Issuer
AMICUS THERAPEUTICS, INC.
CIK 0001178879
Entity typeother
Related Parties
1- filerCIK 0001601896
Filing Metadata
- Form type
- 4
- Filed
- Sep 1, 8:00 PM ET
- Accepted
- Sep 2, 4:27 PM ET
- Size
- 9.9 KB